Regenxbio Inc
RGNX
Market Cap$451.09M
Close$
$25.02
157.6% upside
Current Fair Value
157.6% upsideUndervalued by 157.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $451.09 Million |
|---|---|
| Enterprise Value | $657.20 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.59 |
| Beta | 1.11 |
| Outstanding Shares | 51,483,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.62 |
|---|---|
| PEG | -7.76 |
| Price to Sales | 3.24 |
| Price to Book Ratio | 2.43 |
| Enterprise Value to Revenue | 4.22 |
| Enterprise Value to EBIT | -4.34 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 1.34 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Regenxbio Inc
CEO: Kenneth Mills